When was Biomind Labs founded?

Biomind Labs was founded in 2005 and raised its 1st funding round 16 years after it was founded.

Where is Biomind Labs located?

Biomind Labs is headquartered in Toronto, Canada.

How many employees does Biomind Labs have?

As of Jun 30, 2026, the latest employee count at Biomind Labs is 5.

Is Biomind Labs a funded company?

Biomind Labs is a funded company, having raised a total of $***** in its 1st and only funding round, a Post IPO round on Sep 25, 2021.

When was the latest funding round of Biomind Labs?

Biomind Labs' latest funding was a $***** Post IPO round on Sep 25, 2021, with participation from 0 investor.

Where does Biomind Labs rank among its competitors?

Biomind Labs ranks 11th amongst 100 active competitors, of which 7 are funded. It stands 11th in terms of total funding among its competitors. The most recent competitor to raise funding was MindBio Therapeutics, which secured an undisclosed amount in Apr, 2026.

Who are the top competitors of Biomind Labs?

Biomind Labs' top competitors include Celerion, HMR London and Altasciences. Among them, MindBio Therapeutics secured the most recent funding round in April, 2026.

Biomind Labs - 2026 Company Profile, Funding & Competitors

Company Details

Developer of novel pharmaceuticals targeting neurological disorders and related conditions. The company focuses on transforming biomedical sciences knowledge into fast-acting and controlled-release drugs. Tailored drug delivery systems target specific therapeutic indications beyond mental health. Research and development aims to change lives by providing safe and efficient pharmaceuticals. The company adheres to strict scientific standards to protect patients and ensure reliable clinical trial results.

Key Metrics

Founded Year

2005

Location

Toronto, Canada

Stage

Public

Latest Funding Round

Post IPO, Sep 25, 2021, $*****

Ranked

11^th among 100 active competitors

Employee Count

5 as on Jun 30, 2026

Similar Companies

Celerion & 119 more

Exit Details

Public

View Biomind Labs' full profile

Biomind Labs got listed on Jul 28, 2021.

Click here to take a look at Biomind Labs's IPO in detail

Biomind Labs has raised funding over 1 round.

Here is the list of recent funding rounds of Biomind Labs:

Date of Funding	Funding Amount	Round Name	Post-Money Valuation	Revenue Multiple	Lead Investors	Other Investors
Sep 25, 2021	8686610	Post IPO	5673230	4727686	5295987	2407938

Access funding benchmarks and valuations. Sign up today!

View details of Biomind Labs's funding rounds and investors

Biomind Labs' employee count trend

Biomind Labs has 5 employees as of Jun 26. Here is Biomind Labs's employee count trend over the years:

Uncover Biomind Labs' growth story! Sign up today!

Access Tracxn on any website

Our Google Chrome extension lets you view company details while browsing their websites

Install Tracxn Extension

Top competitors of Biomind Labs include Celerion, HMR London and Altasciences. Here is the list of Top 10 competitors of Biomind Labs, ranked by Tracxn score:

Rank	Company Details	Short Description	Total Funding	Investors	Tracxn Score
1st	Celerion 2010, Lincoln (United States), Acquired	Translational medicine experts accelerating drug development for global patient impact	-	Bain Capital Ventures, H.I.G. Private Equity ... & 7 others	51/100
2nd	HMR London 1993, London (United Kingdom), Acquired	Provider of early phase clinical research services for drug development	-	EIC Fund, Europa	51/100
3rd	Altasciences 2015, Laval (Canada), Acquired	Early phase CRO	-	Apollo Investment Corporation, Signet Healthcare Partners ... & 1 others	50/100
4th	BioPharma Services 2006, Toronto (Canada), Acquired	Provider of early stage clinical trial services	-	-	48/100
5th	MindBio Therapeutics 2021, Melbourne (Australia), Public	Provider of phase I & II clinical trial services for mental health diseases	-	Blackhawk Growth Corp, Hardenbrook Group	44/100
6th	Avance Clinical 2018, Thebarton (Australia), Late Stage	Provider of clinical development services	-	Riverside, Genesis Capital	43/100
7th	Aditum Bio 2019, Cambridge (United States), Unfunded	CRO focused on clinical trial on phase II studies	-	-	42/100
8th	iCardiac Technologies 2006, Rochester (United States), Acquired	Company offering core laboratory services mainly for cardiac safety testing and respiratory diseases	$4M	Stonehenge Growth Equity Partners, Norwest ... & 4 others	41/100
9th	Unravel Biosciences 2020, Boston (United States), Seed	CRO offering early stage clinical development of drugs	$500K	BoxOne Ventures, Beresford Ventures	40/100
10th	Ventura Biomed 2021, Germany, Unfunded	CRO offering early stage drug development services	-	-	40/100
11th	Biomind Labs 2005, Toronto (Canada), Public	Developer of novel pharmaceuticals targeting neurological disorders and related conditions	-	-	39/100